
InnoSer
Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting discovery and preclinical development of drugs. InnoSer’s offerings include its PDXO screening platform for oncology, ADPKD mouse model for nephrology, and a validated midbrain organoid model for Parkinson’s disease. It also provides pathology and genetically engineered mice model services like colony management, cryopreservation, sanitation/rederivation.